Vaxcyte
PCVX
PCVX
293 hedge funds and large institutions have $4.8B invested in Vaxcyte in 2025 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 131 increasing their positions, 75 reducing their positions, and 75 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
6% less funds holding
Funds holding: 313 → 293 (-20)
18% less capital invested
Capital invested by funds: $5.85B → $4.8B (-$1.05B)
23% less first-time investments, than exits
New positions opened: 58 | Existing positions closed: 75
Holders
293
Holding in Top 10
8
Calls
$12M
Puts
$5.37M
Top Buyers
| 1 | +$107M | |
| 2 | +$95.1M | |
| 3 | +$72.2M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
+$54.5M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$45.5M |
Top Sellers
| 1 | -$69.9M | |
| 2 | -$62.3M | |
| 3 | -$50.8M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$47.5M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$43.5M |
